Company Advisors

Sir Gregory Winter

Specialist Advisor to the Board

Sir Gregory is the joint Head of the Division of Protein and Nucleic Acid Chemistry at the MRC Laboratory of Molecular Biology, Cambridge UK, Deputy Director of the MRC Centre for Protein Engineering, Cambridge UK and is a Fellow of Trinity College, Cambridge UK. He founded two Cambridge UK-based biotechnology companies, Cambridge Antibody Technology and Domantis.

His research interests include combinatorial proteins, vaccines and antibodies.

Dr Berwyn Clarke

Specialist Advisor

Dr Clarke is Founder and Chief Scientific Officer of Lab21, a rapidly growing healthcare diagnostics business, providing state-of-the-art diagnostic infectious disease products to blood-banks and clinical labs on a worldwide basis; molecular diagnostic products; and molecular diagnostic services in personalised medicine, mainly in oncology. He played a leading role in taking Lab21 from a start-up in 2005 to a significant global player in diagnostic products and services today with service operations in Europe and North America and sales into over 130 countries. He has over 25 years’ experience in diagnostics and pharmaceuticals working for start-ups and global businesses such as GlaxoWellcome and Bayer Diagnostics.

Professor Ajit Lalvani, MA MBBS DM FRCP FSB

Specialist Advisor on TB

Professor Lalvani is Chair of Infectious Diseases at the National Heart and Lung Institute and Honorary Consultant Physician at Imperial College Healthcare NHS Trust where he directs the Tuberculosis Research Unit. He invented the interferon-gamma release assay (IGRA, ELISpot, T-SPOT.TB), which is the first advance in diagnosis of latent TB in 100-years.

Professor Kheertan Dheda

Specialist Advisor on TB

Professor Keertan Dheda is a general physician, pulmonologist, and a critical care specialist who heads up the Division of Pulmonology at Groote Schuur Hospital and the University of Cape Town. He serves on the editorial boards of several high-ranking international journals, including the American Journal of Respiratory and Critical Care Medicine, has received the several prestigious national and international awards and accolades, including the 2010 International Union Against Tuberculosis and Lung Disease Scientific Award.